199 related articles for article (PubMed ID: 34856327)
21. Advanced glycation end products upregulate lysyl oxidase and endothelin-1 in human aortic endothelial cells via parallel activation of ERK1/2-NF-κB and JNK-AP-1 signaling pathways.
Adamopoulos C; Piperi C; Gargalionis AN; Dalagiorgou G; Spilioti E; Korkolopoulou P; Diamanti-Kandarakis E; Papavassiliou AG
Cell Mol Life Sci; 2016 Apr; 73(8):1685-98. PubMed ID: 26646068
[TBL] [Abstract][Full Text] [Related]
22. Pathological Role of Advanced Glycation End Products (AGEs) and their Receptor Axis in Atrial Fibrillation.
Yamagishi SI; Sotokawauchi A; Matsui T
Mini Rev Med Chem; 2019; 19(13):1040-1048. PubMed ID: 30854960
[TBL] [Abstract][Full Text] [Related]
23. Effect of age receptor blocker and/or anti-inflammatory coadministration in relation to glycation, oxidative stress and cytokine production in stz diabetic rats.
El-seweidy MM; El-Swefy SE; Ameen RS; Hashem RM
Pharmacol Res; 2002 May; 45(5):391-8. PubMed ID: 12123627
[TBL] [Abstract][Full Text] [Related]
24. The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging.
Teissier T; Boulanger É
Biogerontology; 2019 Jun; 20(3):279-301. PubMed ID: 30968282
[TBL] [Abstract][Full Text] [Related]
25. Impact of Advanced Glycation End products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression.
Muthyalaiah YS; Jonnalagadda B; John CM; Arockiasamy S
Glycoconj J; 2021 Dec; 38(6):717-734. PubMed ID: 35064413
[TBL] [Abstract][Full Text] [Related]
26. AGEs, RAGEs and s-RAGE; friend or foe for cancer.
Ahmad S; Khan H; Siddiqui Z; Khan MY; Rehman S; Shahab U; Godovikova T; Silnikov V; Moinuddin
Semin Cancer Biol; 2018 Apr; 49():44-55. PubMed ID: 28712719
[TBL] [Abstract][Full Text] [Related]
27. Dietary advanced glycated end-products and medicines influence the expression of SIRT1 and DDOST in peripheral mononuclear cells from long-term type 1 diabetes patients.
Santos-Bezerra DP; Machado-Lima A; Monteiro MB; Admoni SN; Perez RV; Machado CG; Shimizu MH; Cavaleiro AM; Thieme K; Queiroz MS; Machado UF; Giannella-Neto D; Passarelli M; Corrêa-Giannella ML
Diab Vasc Dis Res; 2018 Jan; 15(1):81-89. PubMed ID: 29027826
[TBL] [Abstract][Full Text] [Related]
28. Advanced glycation end-products and receptor for advanced glycation end-products expression in patients with idiopathic pulmonary fibrosis and NSIP.
Kyung SY; Byun KH; Yoon JY; Kim YJ; Lee SP; Park JW; Lee BH; Park JS; Jang AS; Park CS; Jeong SH
Int J Clin Exp Pathol; 2014; 7(1):221-8. PubMed ID: 24427342
[TBL] [Abstract][Full Text] [Related]
29. Pentoxifylline mitigates renal glycoxidative stress in obese mice by inhibiting AGE/RAGE signaling and increasing glyoxalase levels.
Inacio MD; Costa MC; Lima TFO; Figueiredo ID; Motta BP; Spolidorio LC; Assis RP; Brunetti IL; Baviera AM
Life Sci; 2020 Oct; 258():118196. PubMed ID: 32763295
[TBL] [Abstract][Full Text] [Related]
30. Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension.
Gryszczyńska B; Budzyń M; Begier-Krasińska B; Osińska A; Boruczkowski M; Kaczmarek M; Bukowska A; Iskra M; Kasprzak MP
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412635
[TBL] [Abstract][Full Text] [Related]
31. Pinocembrin Protects from AGE-Induced Cytotoxicity and Inhibits Non-Enzymatic Glycation in Human Insulin.
Borriello M; Iannuzzi C; Sirangelo I
Cells; 2019 Apr; 8(5):. PubMed ID: 31035509
[TBL] [Abstract][Full Text] [Related]
32. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
[TBL] [Abstract][Full Text] [Related]
33. Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes.
Kopytek M; Ząbczyk M; Mazur P; Undas A; Natorska J
Cardiovasc Diabetol; 2020 Jun; 19(1):92. PubMed ID: 32552684
[TBL] [Abstract][Full Text] [Related]
34. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
[TBL] [Abstract][Full Text] [Related]
35. Age-related accumulation of advanced glycation end-products-albumin, S100β, and the expressions of advanced glycation end product receptor differ in visceral and subcutaneous fat.
Son KH; Son M; Ahn H; Oh S; Yum Y; Choi CH; Park KY; Byun K
Biochem Biophys Res Commun; 2016 Aug; 477(2):271-6. PubMed ID: 27301641
[TBL] [Abstract][Full Text] [Related]
36. Receptor for advanced glycation end products in relation to exposure to metal fumes and polycyclic aromatic hydrocarbon in shipyard welders.
Lai CH; Chou CC; Chuang HC; Lin GJ; Pan CH; Chen WL
Ecotoxicol Environ Saf; 2020 Oct; 202():110920. PubMed ID: 32800255
[TBL] [Abstract][Full Text] [Related]
37. Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus.
Choudhuri S; Dutta D; Sen A; Chowdhury IH; Mitra B; Mondal LK; Saha A; Bhadhuri G; Bhattacharya B
Mol Vis; 2013; 19():100-13. PubMed ID: 23378723
[TBL] [Abstract][Full Text] [Related]
38. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.
Hori O; Yan SD; Ogawa S; Kuwabara K; Matsumoto M; Stern D; Schmidt AM
Nephrol Dial Transplant; 1996; 11 Suppl 5():13-6. PubMed ID: 9044300
[TBL] [Abstract][Full Text] [Related]
39. Androgens Increase Accumulation of Advanced Glycation End Products in Granulosa Cells by Activating ER Stress in PCOS.
Azhary JMK; Harada M; Kunitomi C; Kusamoto A; Takahashi N; Nose E; Oi N; Wada-Hiraike O; Urata Y; Hirata T; Hirota Y; Koga K; Fujii T; Osuga Y
Endocrinology; 2020 Feb; 161(2):. PubMed ID: 32020188
[TBL] [Abstract][Full Text] [Related]
40. Advanced glycation end products (AGEs) and their involvement in liver disease.
Hyogo H; Yamagishi S
Curr Pharm Des; 2008; 14(10):969-72. PubMed ID: 18473847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]